S

Sosei Group Corp
TSE:4565

Watchlist Manager
Sosei Group Corp
TSE:4565
Watchlist
Price: 1 033 JPY 1.08% Market Closed
Market Cap: 92.9B JPY
Have any thoughts about
Sosei Group Corp?
Write Note

Sosei Group Corp
Other Non-Cash Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sosei Group Corp
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
S
Sosei Group Corp
TSE:4565
Other Non-Cash Items
ÂĄ1.8B
CAGR 3-Years
N/A
CAGR 5-Years
6%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Non-Cash Items
ÂĄ174.3B
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
37%
Daiichi Sankyo Co Ltd
TSE:4568
Other Non-Cash Items
-ÂĄ25.5B
CAGR 3-Years
-100%
CAGR 5-Years
N/A
CAGR 10-Years
9%
Otsuka Holdings Co Ltd
TSE:4578
Other Non-Cash Items
ÂĄ214.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
64%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Non-Cash Items
ÂĄ101.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Other Non-Cash Items
ÂĄ72.7B
CAGR 3-Years
-5%
CAGR 5-Years
137%
CAGR 10-Years
5%
No Stocks Found

Sosei Group Corp
Glance View

Market Cap
92.9B JPY
Industry
Pharmaceuticals

Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 198 full-time employees. The company went IPO on 2004-07-29. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.

Intrinsic Value
1 330.98 JPY
Undervaluation 22%
Intrinsic Value
Price
S

See Also

What is Sosei Group Corp's Other Non-Cash Items?
Other Non-Cash Items
1.8B JPY

Based on the financial report for Sep 30, 2024, Sosei Group Corp's Other Non-Cash Items amounts to 1.8B JPY.

What is Sosei Group Corp's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
6%

Over the last year, the Other Non-Cash Items growth was 290%.

Back to Top